The Paper “Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)” summarizing the research on a treatment that combines Boron Neutron Capture Therapy (BNCT) with immune checkpoint inhibitors (ICIs) was published in the journal “Cancer Science”.
The paper indicates that better therapeutical effects can be expected through the research on improving BNCT by combining Stella Pharma’s boron compound with ICI immunotherapy.
The paper can be found following this link.